Semanteon Capital Management LP Has $623,000 Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Semanteon Capital Management LP grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 115.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 66,776 shares of the pharmacy operator's stock after purchasing an additional 35,774 shares during the period. Semanteon Capital Management LP's holdings in Walgreens Boots Alliance were worth $623,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. State Street Corp lifted its position in Walgreens Boots Alliance by 18.0% during the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator's stock worth $385,258,000 after buying an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Walgreens Boots Alliance by 43.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator's stock valued at $98,284,000 after acquiring an additional 3,329,857 shares during the last quarter. Two Sigma Advisers LP bought a new stake in Walgreens Boots Alliance during the third quarter worth about $24,226,000. Amundi boosted its position in Walgreens Boots Alliance by 70.3% during the fourth quarter. Amundi now owns 4,455,720 shares of the pharmacy operator's stock valued at $41,082,000 after purchasing an additional 1,839,045 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $9,685,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on WBA. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. StockNews.com assumed coverage on Walgreens Boots Alliance in a report on Wednesday. They set a "hold" rating for the company. Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Bank of America upped their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research note on Monday, January 13th. Finally, Evercore ISI boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a report on Monday, January 13th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Walgreens Boots Alliance has a consensus rating of "Hold" and an average price target of $10.59.

Walgreens Boots Alliance Price Performance

Shares of WBA traded down $0.02 during trading hours on Wednesday, hitting $11.10. 9,879,860 shares of the company were exchanged, compared to its average volume of 20,715,027. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.05. The company has a market cap of $9.59 billion, a price-to-earnings ratio of -1.08, a P/E/G ratio of 1.31 and a beta of 0.62. The firm's fifty day moving average is $10.92 and its 200 day moving average is $9.87.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business's revenue for the quarter was up 7.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.66 earnings per share. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.